Travere Therapeutics Inc (TVTX) — the peer cohort
As of 2026-11-18 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
Travere Therapeutics Inc ranks 7 of 7 in its cohort on the Closelooknet composite (44/100) — the cohort is led by Halozyme Therapeutics Inc at 72/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics Inc | 44 | 58 | 34 | 18 | info | 26.9% |
| HALO Halozyme Therapeutics Inc | 72 | 69 | 94 | 49 | info | 28.5% |
| ONC BeOne Medicines AG | 66 | 87 | 68 | 29 | ok | 5% |
| REGN Regeneron Pharmaceuticals Inc | 65 | 90 | 73 | 47 | watch | 3.4% |
| ARGX.BR Argen-X | 64 | 77 | 75 | 26 | ok | 7.1% |
| RIGL Rigel Pharmaceuticals Inc | 64 | 75 | 89 | 76 | info | 19.2% |
| UCB.BR UCB SA | 64 | 75 | 71 | 42 | info | 5.3% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-11-18
Quick answers
Who are Travere Therapeutics Inc's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Halozyme Therapeutics Inc (HALO), BeOne Medicines AG (ONC), Regeneron Pharmaceuticals Inc (REGN), Argen-X (ARGX.BR), Rigel Pharmaceuticals Inc (RIGL), UCB SA (UCB.BR), as of 2026-11-18.
How does TVTX score against its peers?
Travere Therapeutics Inc's composite reads 44/100, ranking 7 of 7 in its cohort as of 2026-11-18; the cohort's highest composite is Halozyme Therapeutics Inc at 72/100. Closelooknet scores are research diary readings, not ratings or advice.
Mentioned on Closelooknet
Where TVTX appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ONC BeOne Medicines AGindustry
- REGN Regeneron Pharmaceuticals Incindustry
- ARGX.BR Argen-Xindustry
- RIGL Rigel Pharmaceuticals Incindustry
- UCB.BR UCB SAindustry
- SLS Sellas Life Sciences Group Incindustry
- VCEL Vericel Corp Ordindustry
- REPL Replimune Group Incindustry
- VRDN Viridian Therapeutics Incindustry
- ADMA ADMA Biologics Incindustry
- XNCR Xencor Incindustry
- KOD Kodiak Sciences Incindustry
- RPRX Royalty Pharma Plcindustry
- IRON Disc Medicine Inc.industry
- EXEL Exelixis Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- MEDCL.PA Medincell SAindustry
- MAZE Maze Therapeutics, Inc. Common Stockindustry